CD44 and neoplasm: Recently, several articles revealed that targeting CD44 positive tumor cells with anti-CD44 monoclonal antiboby apparently inhibited proliferation and promoted apoptosis of sphere forming cells [34], and improved cells uptake of other anti-tumor chemicals [35], but the efficiency was influenced by CD44 isoform status [36].